Management & Regulatory

Capra Biosciences Secures $7.5M for AI-Driven Biomanufacturing Project
Management & Regulatory Capra Biosciences Secures $7.5M for AI-Driven Biomanufacturing Project

The biomanufacturing industry is on the cusp of a transformative era, driven by technological innovations and strategic financial investments. A recent $7.5 million project agreement awarded to Capra Biosciences by the U.S. Department of Health and Human Services’ Administration for Strategic P

Enhancing Data Integrity in Pharma with Automation to Meet ALCOA+
Management & Regulatory Enhancing Data Integrity in Pharma with Automation to Meet ALCOA+

Pharmaceutical manufacturing is evolving rapidly to keep pace with increasing global demand and stringent regulatory standards. A critical aspect of this evolution is the integration of automation systems to enhance data integrity. Automation ensures compliance with the ALCOA+

Is AbbVie Poised for Growth with Its 2022 Financial Strategy and Acquisitions?
Management & Regulatory Is AbbVie Poised for Growth with Its 2022 Financial Strategy and Acquisitions?

AbbVie's financial performance and strategic initiatives in 2022 demonstrate a concerted effort to drive growth and enhance its presence in the pharmaceutical and biopharmaceutical sectors. With revenues exceeding $58 billion, the year reflected significant advancements fueled by new product

How Is Rentschler Biopharma Shaping the Future of Advanced Therapies?
Management & Regulatory How Is Rentschler Biopharma Shaping the Future of Advanced Therapies?

Rentschler Biopharma, a fifth-generation, family-owned German biopharmaceutical company, has made tremendous strides in the field of advanced therapies. With its roots tracing back over 150 years, Rentschler has carved out a unique position in the biotechnology landscape, emphasizing innovation,

Rentschler Biopharma Expands U.S. Facility to Boost ATMP Production
Management & Regulatory Rentschler Biopharma Expands U.S. Facility to Boost ATMP Production

Rentschler Biopharma, a renowned contract development and manufacturing organization (CDMO), has recently made significant strides in expanding its facilities and operational capabilities. Located in Milford, Massachusetts, the new addition emphasizes the company's dedication to the burgeoning

Will J&J or Novartis Acquire Legend Biotech Amid Market Speculation?
Management & Regulatory Will J&J or Novartis Acquire Legend Biotech Amid Market Speculation?

The biopharma industry is abuzz with rumors of a potential takeover of CAR-T specialist Legend Biotech, a company renowned for its collaboration with Johnson & Johnson (J&J) on the BCMA CAR-T therapy Carvykti. An unnamed source cited by StreetInsider has revealed that Legend recently

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later